My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

TRACON Pharmaceuticals, Inc. - Common Stock (NQ:TCON)

1.430 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jun 27, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about TRACON Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 02, 2021

Gainers Omeros (NASDAQ:OMER) stock increased by 15.68% to $7.89 during Thursday's pre-market session. The market value of their outstanding shares is at $493.4 million...

Via Benzinga

Week In Review: Shanghai's Zenas Acquires CD19 Antibody From Xenco In $480 Million Deal ↗

November 27, 2021

In a $480 million deal, Zenas acquired global rights to a bifunctional antibody from Xencor that targets CD19. Instead of an upfront payment, Zenas will issue a warrant granting Xencor the right to...

Via Talk Markets

5 Stocks Insiders Are Still Buying (Even As Others Cash Out) ↗

November 12, 2021

Insider sales are generally a sign the market is about to drop, but not everyone's selling. Here are five companies with insider buying.

Via InvestorPlace

Week In Review: Hansoh Signs $456 Million Deal For siRNA Products ↗

October 16, 2021

Hansoh Pharma of Shanghai announced a $456 million agreement to develop siRNA products in Greater China from South Korea's OliX Pharma. Hansoh will make an upfront payment of $6.5 million and up to...

Via Talk Markets

Capital Efficient: Clinical Stage NASDAQ Company - Novel Targeted Cancer Therapeutics Company: TRACON Pharmaceuticals (NASDAQ: TCON)

August 16, 2021

Via Viz Release

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

Earnings Scheduled For November 3, 2021 ↗

November 03, 2021

Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion....

Via Benzinga

TRACON Pharma, Eucure Join Forces To Develop CTLA-4 Antibody For Oncology Indications ↗

October 11, 2021

TRACON Pharmaceuticals Inc (NASDAQ: TCON) entered into a collaborative partnership agreement with Eucure Biopharma, a subsidiary of Biocytogen Pharmaceuticals (...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 11, 2021

Gainers Protagonist Therapeutics (NASDAQ:PTGX) shares moved upwards by 89.3% to $34.53 during Monday's pre-market session. The market value of their outstanding shares is at...

Via Benzinga

TRACON Pharmaceuticals on the Fast Track for Sarcoma Injection Treatments ↗

September 07, 2021

Sarcoma is not one of the many cancers that reaches top billing in the discussion of cancer research. The cancer starts in tissues like bone, muscle or soft tissue and...

Via Benzinga

25.6 Million in cash will Bankroll this NASDAQ until 2023; Capitol Efficient Clinical Stage, Novel Targeted Cancer Therapeutics: TRACON Pharmaceuticals (NASDAQ: TCON)

August 31, 2021

Via Viz Release

3 Penny Stocks Insiders Are Buying ↗

July 28, 2021

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider...

Via Benzinga

The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma ↗

August 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (...

Via Benzinga

Earnings Scheduled For August 11, 2021 ↗

August 11, 2021

Companies Reporting Before The Bell • Wireless Telecom Group (AMEX:WTT) is likely to report earnings for its second quarter. • Gamida Cell (NASDAQ:GMDA) is...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 26, 2021

Gainers Eyegate Pharmaceuticals (NASDAQ:EYEG...

Via Benzinga

61 Biggest Movers From Yesterday ↗

July 23, 2021

Gainers ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) shares jumped 138.2% to close at $13.22 on Thursday after the company announced new results from its TATX-03 PolyTope Therapy...

Via Benzinga

Mid-Afternoon Market Update: Dow Rises Over 50 Points; ImmunoPrecise Antibodies Shares Spike Higher ↗

July 22, 2021

Toward the end of trading Thursday, the Dow traded up 0.16% to 34,853.89 while the NASDAQ rose 0.38% to 14,687.85. The S&P also rose, gaining 0.20% to 4,367.55. The U.S. has...

Via Benzinga

Topics Stocks

38 Stocks Moving In Thursday's Mid-Day Session ↗

July 22, 2021

Gainers ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) shares climbed 129.7% to $12.75 after the company announced new results from its TATX-03 PolyTope Therapy, demonstrating...

Via Benzinga

Mid-Day Market Update: Crude Oil Up 1.5%; Seres Therapeutics Shares Plunge ↗

July 22, 2021

Midway through trading Thursday, the Dow traded down 0.08% to 34,768.64 while the NASDAQ rose 0.10% to 14,646.39. The S&P also fell, dropping 0.02% to 4,357.70. The U.S. has...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 22, 2021

Gainers NRX Pharmaceuticals (NASDAQ:NRXP) stock increased by 53.01% to $15.47 during Thursday's regular session. As of 12:30 EST, this security is trading at a volume...

Via Benzinga

Mid-Morning Market Update: Markets Mostly Lower; AT&T Beats Q2 Estimates ↗

July 22, 2021

Following the market opening Thursday, the Dow traded down 0.24% to 34,715.42 while the NASDAQ rose 0.13% to 14,651.19. The S&P also fell, dropping 0.08% to 4,355.29. The U.S...

Via Benzinga

Topics Stocks

The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, AbSci IPO ↗

July 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 21) Biohaven Pharmaceutical...

Via Benzinga

21 Stocks Moving in Thursday's Pre-Market Session ↗

July 22, 2021

Gainers PainReform Ltd (NASDAQ: PRFX) shares rose 123% to $7.00 in pre-market trading. Second Sight Medical Products Inc (NASDAQ: EYES) shares rose 29% to $5.57 in pre-market...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 21, 2021

Gainers Second Sight Medical (NASDAQ:EYES

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

July 02, 2021

Gainers Odonate Therapeutics (NASDAQ:ODT)...

Via Benzinga

58 Biggest Movers From Friday ↗

June 21, 2021

Gainers CAI International, Inc. (NYSE: CAI) shares surged 46.9% to close at $56.05 on Friday after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc....

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

June 18, 2021

Gainers Geron (NASDAQ:GERN) shares increased by 53.19% to $2.16 during Friday's regular session. As of 12:33 EST, Geron's stock is trading at a volume of 179.2...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 4, 2021 ↗

June 04, 2021

Upgrades According to Argus Research, the prior rating for Diageo PLC (NYSE:DEO) was changed from Hold to Buy. The current stock performance of Diageo shows a 52-week-high...

Via Benzinga

The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes ↗

May 31, 2021

After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-...

Via Benzinga

The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues ↗

May 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.